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Abstract We present here the purification and the analysis of
the structural and functional properties of distinctin, a 5.4 kDa
heterodimeric peptide with antimicrobial activity from the tree-
frog Phyllomedusa distincta. This peptide was isolated from the
crude extract of skin granular glands by different chromato-
graphic steps. Its minimal inhibitory concentration was deter-
mined against pathogenic Escherichia coli, Staphylococcus
aureus, Enterococcus faecalis and Pseudomonas aeruginosa
strains. Amino acid sequencing and mass spectrometric investi-
gations demonstrated that distinctin is constituted of two
different polypeptide chains connected by an intermolecular
disulphide bridge. Circular dichroism and Fourier-transformed
infrared spectroscopy studies showed that this molecule adopts,
in water, a structure containing a significant percentage of anti-
parallel L-sheet. A conformational variation was observed under
experimental conditions mimicking a membrane-like environ-
ment. Database searches did not show sequence similarities with
any known antimicrobial peptides. In the light of these results, we
can consider distinctin as the first example of a new class of
antimicrobial heterodimeric peptides from frog skin. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
Key words: Antimicrobial peptide; Disulphide; Heterodimer;
Conformation analysis ; Phyllomedusa distincta
1. Introduction
Antimicrobial peptides, small toxins and venom compo-
nents have long been identi¢ed in a wide range of organisms
as parts of complex defence mechanisms as well as invaluable
predatory weapons [1^3]. Amphibian peptides represent an
important chapter in the vastly investigated area of antimicro-
bial substances; they have been shown to inhibit the growth
of numerous species of bacteria, fungi, protozoa and also
some types of tumour cells without showing signi¢cant hae-
molytic activity [4,5]. These molecules range in length from
less than 15 to more than 40 amino acid residues with most
having a net positive charge and a potential amphipathic K-
helical conformation. In addition, they possess a high hydro-
phobic moment, a broad non-polar face and a narrow polar
face. Although their mechanism of action is not totally under-
stood, studies in the presence of lipid bilayers as models of
biological membranes demonstrated that these peptides fold
into amphipathic K-helices when bound to the lipid mem-
brane. In this process, it is thought that these molecules per-
meabilise the bilayer either by forming pores consisting of sets
of associated peptide helices or by simple disrupting the lipid
acyl chain packing in the membrane [6,7].
Among the known antimicrobial peptides from amphibians,
magainins (isolated from Xenopus laevis), esculentins, brevi-
nins, ranatuerins and ranalexin (from Rana sp.), dermaseptins
(from Phyllomedusa sp.) and bombinins (from Bombina sp.)
have been shown to act by enhancing the permeability of
biological membranes [4,5,8]. These helical peptides have
been classi¢ed in ¢ve di¡erent groups by combining sequence
homologies, functional similarities and conformational prop-
erties. Esculentins, brevinins, ranatuerins and ranalexins are
characterised by the presence of an intramolecular S^S bridge
at the C-terminus containing a loop of six or seven residues
that resembles the cyclic hepta-peptide or the penta- and octa-
depsipeptide moieties observed in membrane active compo-
nents isolated from Bacillus polymyxa and Pseudomonas sy-
ringae, respectively [9].
Other antimicrobial peptides with one or more intramolec-
ular S^S bridges have been isolated from di¡erent animals.
Only a single disulphide bond is found in a cyclic dodecapep-
tide from bovine neutrophils [10]. All other molecules have at
least two or three S^S bridges; for example defensins isolated
from mammalian granulocytes, L-defensins puri¢ed from
chicken leukocytes and mammalian tissues, protegrins from
porcine leukocytes and cysteine-rich peptides from inverte-
brates [2,3,11]. Similarly, a high disulphide bonds content
has been reported in several antibacterial peptides puri¢ed
from plants [12]. Most of these molecules present a substantial
degree of amphipathic L-sheet structure [2,11].
Among a great number of dermaseptin-related components
present in skin extracts of Phyllomedusa distincta [13], we iso-
lated a new antimicrobial peptide. In this work we describe
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the puri¢cation, the structural characterisation, the conforma-
tional analysis and the biological activity of this S^S bridged
heterodimer.
2. Materials and methods
2.1. Materials
P. distincta specimens were captured in Itanhae¤m, Sa‹o Paulo State,
Brazil. All solutions were prepared using water from a Milli-Q appa-
ratus (Millipore). Solvents were high performance liquid chromatog-
raphy (HPLC) grade. All reagents were analytical grade.
2.2. Peptide puri¢cation
Frog skin secretion was obtained by manual compression of the
granular glands and collected in distilled water as a crude extract.
This material was ¢ltered by gravity in paper ¢lter, frozen in liquid
nitrogen and lyophilised. Peptide separation was performed as previ-
ously reported [13]. Peptides were manually collected and lyophilised.
Independent collections from di¡erent individuals at various times
were performed.
2.3. Reduction and alkylation reaction
Peptide samples were reduced in 0.25 M Tris^HCl, 1.25 mM
EDTA, pH 8.5, by incubation with a 10:1 molar excess of dithiothrei-
tol over the molecule ^SH groups, at 37‡C for 2 h, under N2 atmos-
phere, and alkylated using a 10:1 molar excess of iodoacetamide over
the total ^SH groups, for 1 h at 25‡C, in the dark, under N2 atmos-
phere. Carboxyamidomethylated peptides were puri¢ed, manually col-
lected and lyophilised.
2.4. Sequence determination
The N-terminal sequence of either native and alkylated samples of
peptides was determined using an Applied Biosystems 477A pulsed-
liquid protein sequencer. Quantitative amino acid composition of pure
peptide was determined with a 6300 E Beckman amino acid analyser
(Palo Alto, CA, USA). Samples were hydrolysed in 6 N HCl, con-
taining 0.5% phenol, in sealed and evacuated Pyrex glass tubes for 24 h
at 110‡C. Peptide mass determination was obtained using a Platform
single quadrupole mass spectrometer (Micromass, Manchester, UK)
as previously reported [13].
2.5. Antimicrobial tests
The microorganisms used for the antimicrobial assay were pur-
chased from American Collection (Rockville, MD, USA). They
were Enterococcus faecalis ATCC 29212, Pseudomonas aeruginosa
ATCC 27853, Staphylococcus aureus ATCC 25923 and Escherichia
coli ATCC 25922. To reactivate the freeze-dried E. faecalis, the strain
was cultured with shaking at 30‡C; the other microorganisms were
cultured in stationary culture at 37‡C. Bacteria were grown in tryptic
soy broth. The bioassays were performed by the microdilution method
as previously reported [13].
2.6. Spectroscopy studies
Circular dichroism (CD) spectra were recorded by using a Jasco
J-720 spectropolarimeter (Easton, MD, USA) calibrated with D-10-
camphorsulphonic acid. The peptides were dissolved in water or
water/2,2,2-tri£uoroethanol (TFE) solutions (0.250 mg/ml) and ana-
lysed in a cell of 0.10 cm path length, at room temperature. CD band
intensities are represented as mean residue ellipticity. Percentage of
secondary structure elements was calculated using a method based on
linear combination of CD spectra obtained from proteins with known
secondary structures [14].
Infrared spectroscopic studies were performed with a PROTA1
Fourier-transformed infrared (FTIR) protein analyser (Bomem/Vysis,
USA). The instrument is based on Bomem’s MB-104 FTIR spectrom-
eter, equipped with a DTGS detector, non-hygroscopic ZnSe beam-
splitter and Arid-Zone purge system. This system con¢guration is
optimised for measurement of protein spectra at low protein
concentrations in aqueous solutions and to minimise water vapour
interference. Spectra were collected in the transmission mode at a
resolution of 4 cm31, accumulating 500 scans obtained with a scan
speed of 20 scan/min. The peptide was dissolved in water at a con-
centration of 1.0 mg/ml. A demountable cell with a 6 W mylar spacer
(Specac Ltd., UK) was used, although the cell was not taken apart
during the experiment in order to keep the path length constant. A
water blank was subtracted using an automated algorithm present in
the instrument software, that uses linear regression to minimise the
combination band of water at V2125 cm31. Second derivative and
Fourier self-deconvolution spectra were calculated to enhance the
spectral features using Spectrum Square Associates (Ithaca, NY,
USA) software available within the instrument. Lorentzian bandshape
was assumed for both calculations, with full width at half-height equal
to 14 cm31 for second derivative and 16 cm31 for deconvolution, with
additional parameter k equal to 1.8 (where k is de¢ned as original
width divided by new width). Quantitative secondary structure calcu-
lations were performed using Factor Analysis algorithm available with
the instrument software [15].
2.7. Secondary structure prediction and model construction
Secondary structure prediction was carried out using PHD [16]. A
model of the chain 2 was constructed using O [17], assuming a helical
orientation parallel to the lipid chains [8]. Symmetrical helical bundles
were constructed with the helical axis orientation chosen to maximise
the exposure of hydrophilic residues to the central channel. Side
chains were modelled as the most common rotamers [18]. In order
to sample conformational space more e¡ectively we used MODEL-
LER [19], with a 4 Aî randomisation step prior to restraint re¢nement,
to ‘breed’ more structures from the original model. Strong restraints
were applied to enforce exact 6-fold symmetry. We used PROCHECK
[20] for geometrical analysis of the ¢nal model.
3. Results
Initial fractionation of P. distincta crude gland extracts sep-
arated more than 30 components [13]. Species were further
puri¢ed on an analytical reversed-phase column. This proce-
dure allowed obtaining di¡erent peptides not yet known in a
homogeneous form, as judged by HPLC pro¢le and electro-
spray mass spectrometry (ESMS) analysis. A general screen-
ing of all species isolated was performed to ¢nd lytic activity
against synthetic membranes using large unilamellar vesicles
(LUVs) constructed with phosphatidylcholine. Previous stud-
ies on other antimicrobial peptides demonstrated that the abil-
ity to disrupt synthetic membranes like liposomes could be
related to their antimicrobial activity [8]. Among a number
of dermaseptin-related species [13], a strong lytic activity
against LUVs was associated also to peptide N.
Although ESMS analysis of this component revealed only
the occurrence of a single species with a molecular mass of
5478.4 þ 0.6 Da, primary structure investigations by auto-
mated Edman degradation yielded a simultaneous double se-
quence, corresponding to two independent peptides consisting
of more than 20 amino acid residues each. Indeed, reversed-
phase HPLC analysis of peptide N, following reduction and
alkylation reactions, yielded two di¡erent species, as reported
in Fig. 1A. Their molecular masses were measured by ESMS
(Fig. 1B,C). Automated Edman degradation of each peak
yielded unequivocal results allowing the reconstruction of
the primary structure of each peptide. The theoretical molec-
ular masses calculated from the sequences for the carboxy-
amidomethylated peptides (2584.0 Da and 3010.5 Da, respec-
tively) were in excellent agreement with the values
experimentally determined. These results, together with unsuc-
cessful attempts to alkylate and resolve peptide N without
prior treatment with reductive agents, clearly demonstrated
that the cysteine residues present in each peptide chain were
linked by a disulphide bridge to yield a heterodimeric species
whose theoretical molecular mass (5478.6 Da) was in excellent
agreement with the value experimentally determined for pep-
tide N. The molecular structure determined for this lytic com-
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ponent, here named distinctin on the basis of the amphibian
species name, is reported in Fig. 2. Minor amounts of a trun-
cated species missing three amino acid residues at the N-ter-
minus of chain 1 were also identi¢ed in some preparations.
Due to its poor relative abundance, this species was not con-
sidered for biological assays. A search in di¡erent protein
databases did not show similarity of distinctin to other known
antimicrobial peptides, strongly suggesting that this molecule
could be considered as the ¢rst example of a new class of lytic
peptides isolated from frog skin.
Distinctin was tested for antimicrobial activity against the
pathogenic bacteria species E. faecalis, P. aeruginosa, S. aur-
eus and E. coli, respectively. Minimal inhibitory concentration
(MIC), de¢ned as the smallest amount of peptide capable of
inhibiting bacteria growth, was determined for the peptide
using ampicillin, chloramphenicol, neomycin and tetracycline
for comparison purposes. The results are shown in Table 1.
The peptide concentration corresponding to MIC was added
to a culture of solid tryptic soy medium for 24 h at 37‡C and
no colony was grown in all cases. These experiments demon-
strated that distinctin showed a marked antimicrobial activity
against both Gram-positive and Gram-negative bacteria, com-
parable to conventional antibiotics. Given the increasing in-
cidence of multiply resistant bacterial infections, peptides such
as distinctin may present an alternative route for the develop-
ment of therapeutic compounds.
In order to get information regarding the conformation of
distinctin in aqueous solution, the peptide was analysed by
two complementary approaches: CD and FTIR spectroscop-
ies. CD studies clearly demonstrated that this peptide pre-
sented in water a structured conformation. Fig. 3 shows the
CD spectrum pro¢le obtained; the single minimum observed
at 195^200 nm for native distinctin was characteristic of poly-
peptides containing L-sheet and L-turn secondary structure
with some random coil [14]. The calculated content of second-
ary structure elements pointed out that distinctin presents an
organised structure with predominant anti-parallel L-sheet
conformation: 41.7% L-sheet (anti-parallel), 4.1% L-sheet
(parallel), 9.8% K-helix, 18.3% L-turn and 26.0% random coil.
The FTIR absorbance spectrum of distinctin is shown in
Fig. 4A. The spectrum obtained is typical for polypeptides
with a high L-sheet content, although mixed with other struc-
tural elements, as demonstrated by the dominance of 1624
cm31 and 1650 cm31 bands [21]. Fig. 4B shows second deriv-
ative (top) and Fourier self-deconvolution (bottom) spectra
for an expanded region of the amide I band. These spectra
emphasised the dominance of L-sheet content (main band at
1624 cm31 with a smaller band at 1683 cm31) with respect to
helices and turns. By using the Factor Analysis program a
content of 38% L-sheet, 25% K-helix, 17% turns and 11%
bend was calculated.
The results of the antibacterial assays and conformational
analysis suggested that distinctin, commonly to other pep-
Fig. 1. Reversed-phase HPLC analysis of distinctin following reduc-
tion and alkylation (A). Transformed ESMS spectrum of the pep-
tide corresponding to peak 1 (B) and peak 2 (C).
Fig. 2. Molecular structure of distinctin. Secondary structure predic-
tion is shown.
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tides, might form pores in lipid bilayers by adopting a typical
transmembrane L-structure observed also in other classes of
pore forming peptides and proteins [22,23]. However, a care-
ful examination of its sequence showed a clear absence of the
alternating hydrophobic/hydrophilic amphipathic pattern
characteristic of membrane-spanning L-strands [23]. In con-
trast, secondary structure prediction revealed a signi¢cant
propensity for chain 2 to form an K-helix in the region 2^21
(Fig. 2). Helical wheel diagrams showed that this portion
would form a highly amphipathic helix (data not shown).
This result suggested that distinctin, like many other peptides,
might alternatively form a transmembrane channel through
the parallel association of amphipathic K-helices. To investi-
gate this possibility we performed CD analysis under exper-
imental conditions mimicking a membrane-like environment.
Fig. 3 reports the CD spectra obtained at increasing TFE
concentrations. A signi¢cant conformational change was ob-
served, associated with a strong increase in helical content and
a parallel decrease in anti-parallel L-sheet content. In fact, the
calculated percentage of secondary structure elements for dis-
tinctin in 40% TFE resulted: 21.4% L-sheet (anti-parallel),
7.4% L-sheet (parallel), 25.0% K-helix, 19.3% L-turn and
27.0% random coil, respectively.
In order to investigate on the possible distinctin folding in
membranes, we carried out structural modelling of chain 2
(data not shown). We excluded the possibility that chain 1
might also span membranes because of its much shorter ex-
tension compared with the accepted minimum for transmem-
brane helices [24,25]. The largely hydrophilic face of the pu-
tative chain 2 helix would favour a large number of
associating helices [26,27]. Indeed, four and six helical bundle
models were generated and analysed for their structure. The
six helical bundle model presented a more favourable packing,
with all hydrophobic residues positioned to allow interaction
with lipid chains or participation in inter-helical packing and
all hydrophilic residues positioned where they would contact
the water-¢lled channel. According to this model, the C-ter-
minal part of both chains would be hypothesised as located
near the membrane surface, with their basic residues concen-
trated in the vicinity of the disulphide bond and interacting
with the negatively charged phospholipid head-groups.
4. Discussion
Among a great number of antimicrobial peptides isolated
from the frog skin of P. distincta [13], a new heterodimeric
peptide, distinctin, was isolated and structurally characterised.
Heterodimeric structures connected by a single intermolecular
S^S bond were reported only for invertebrates neurotoxins
inhibiting neurotransmitter release, imperatoxin I and L-bun-
garotoxins [28]. The occurrence of an antimicrobial heterodi-
meric polypeptide has not been described so far, although the
isolation of a homodimeric antibacterial component from the
guinea pig neutrophils has been reported [29]. These ¢ndings
lead us to consider distinctin as the ¢rst example of a new
class of bioactive peptides from frog skin.
Antimicrobial peptides interacting with membranes have
been proposed to fall into two distinct structural groups:
those containing amphipathic K-helices forming a channel in
membranes and those with L-structure oligomerising to gen-
erate a transmembrane L-barrel [22]. Distinctin extends the
range of known lytic molecules further since, while being
Table 1
MIC of distinctin compared to other conventional antibiotics
Bacterium Distinctin Ampicillin Chloramphenicol Neomycin Tetracycline
E. coli 14.5 50.0 50.0 100.0 50.0
S. aureus 28.0 6 0.7 100.0 25.0 6.2
P. aeruginosa 28.0 s 100.0 s 100.0 s 100.0 100.0
E. fecalis 14.5 N.d. N.d. N.d. N.d.
The concentration is expressed in WM. N.d.: not determined.
Fig. 3. CD analysis of distinctin in the far-ultraviolet region. The
spectra were performed in water (A), 10% TFE (B), 20% TFE (C)
and 40% TFE (D), respectively.
Fig. 4. FTIR absorbance spectrum of distinctin (A). The spectrum
was obtained in water as described in Section 2. Calculated second
derivative (top) and deconvoluted (bottom) spectra (B).
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rich in L-structure, it seems to lack the potential to form
amphipathic L-strands. In fact, CD measurements and sec-
ondary structure prediction suggested that one of its chains
should be capable to form an amphipathic transmembrane
helix as a result of a conformational adjustment on moving
from water to a lipid environment. Some bacterial toxins,
such as colicin [30] and aerolysin [31], exhibit only tertiary
structure rearrangement on insertion into the membrane. Sim-
ilarly, a growing number of peptides are known to undergo
changes in secondary structural content, involving an increase
in helical structure, on membrane insertion. Among these are
cytolysins and equinatoxin II, both obtained from sea ane-
mone [32]. It seems that distinctin falls within this group.
However, it has to be mentioned that the model here pro-
posed is not supported by any direct experimental observa-
tion. Such issues will be de¢nitively addressed by nuclear mag-
netic resonance spectroscopic studies in water and in micelles,
now in progress. Additional investigations on its haemolytic
activity will clarify its possible use as therapeutic compound.
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